• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • 2026 Election
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2026 Election
  • Trump Administration
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Pharmaceutical Industry

    Tag: Pharmaceutical Industry

    In this article, Rep. Andy Biggs, R-Ariz., lists some of his legislative initiatives in Congress during 2017. (AP Photo/Ross D. Franklin)
    Education

    Rep. Andy Biggs: I kept my campaign promises by introducing or sponsoring these bills

    Rep. Andy Biggs -
    December 29, 2017 8:42 pm
    0
    In this 2006 photo, Wal-Mart pharmacy technician Mark Pool fills a generic anti-inflammatory prescription at a Little Rock, Ark., Wal-Mart Super Center store. While the Constitution allows for patents, patents are temporary monopolies, meaning that drug companies want to extend their effective life as much as possible - much to the detriment of generics. (AP Photo/Mike Wintroath)
    Healthcare

    Congress can liberate drugs that come off their patents

    Peter Ferrara -
    December 26, 2017 5:01 am
    0
    Opioids made up the largest proportion of drug-related deaths. Roughly half of opioid-related deaths were caused by fentanyl, a highly potent opioid that has been described as 50 times stronger than heroin. (AP Photo/Jacquelyn Martin)
    Healthcare

    Opioid deaths rose for men and women of all ages in 2016

    Kimberly Leonard -
    December 21, 2017 1:52 pm
    0
    Sens. Susan Collins, R-Maine, and Bill Nelson, D-Fla., have sponsored legislation to give states $10 billion in 2019 and 2020 to set up a reinsurance program. Reinsurance pays an insurer for the highest medical claims, which in turn would reduce premiums for everyone else. (AP Photo/Evan Vucci)
    Healthcare

    Bill would reverse premium increases from repealing Obamacare mandate, report finds

    Robert King -
    December 19, 2017 11:53 pm
    0
    A new report released Tuesday found there were roughly 225,000,000 prescriptions of opioids that include hydrocodone and oxycodone dispensed in 2016, compared to roughly 275,000,000 in 2012. (AP Photo/Patrick Sison)
    Healthcare

    Number of opioid prescriptions down 16 percent over the last four years

    Robert King -
    December 19, 2017 3:17 pm
    0
    The IRS cannot predict what loopholes and workarounds corporations and individuals might find under the revised tax code Republicans are expected to pass Tuesday. (Andrew Harrer/Bloomberg)
    Economy

    IRS to get massive new workload when GOP tax bill becomes law

    Joseph Lawler -
    December 19, 2017 11:00 am
    0
    Healthcare

    Lawmakers zero in on next target in fight against high drug prices

    Robert King -
    December 17, 2017 5:01 am
    0
    Industry groups try to deflect blame, while being chided by senators for the rising cost of prescription drugs. (AP Photo/Rich Pedroncelli)
    Healthcare

    Senators want to clamp down on drugmakers’ patent protections

    Robert King -
    December 12, 2017 8:33 pm
    0
    Healthcare

    Republicans frustrated over backlash on opioid law

    Kimberly Leonard -
    December 12, 2017 4:42 pm
    0
    House Republicans and their counterparts in the Senate must sort out the differences between their two tax reform bills in order to meet the arbitrary Christmas deadline they set for themselves. (AP Photo/J. Scott Applewhite)
    Economy

    Republicans race the clock to finish tax reform before Christmas

    Joseph Lawler -
    December 7, 2017 5:01 am
    0
    1...101102103...156Page 102 of 156
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.